Giuseppe Giaccone

1986–2025 年に発表

260
論文数
61,039
被引用数
128
h 指数
260
i10 指数

被引用数

Giuseppe Giaccone の年別被引用数1971 年: 被引用 1 件1988 年: 被引用 2 件1989 年: 被引用 1 件1990 年: 被引用 4 件1991 年: 被引用 6 件1992 年: 被引用 11 件1993 年: 被引用 11 件1994 年: 被引用 11 件1995 年: 被引用 11 件1996 年: 被引用 29 件1997 年: 被引用 38 件1998 年: 被引用 46 件1999 年: 被引用 73 件2000 年: 被引用 72 件2001 年: 被引用 89 件2002 年: 被引用 156 件2003 年: 被引用 209 件2004 年: 被引用 313 件2005 年: 被引用 450 件2006 年: 被引用 409 件2007 年: 被引用 371 件2008 年: 被引用 346 件2009 年: 被引用 376 件2010 年: 被引用 391 件2011 年: 被引用 487 件2012 年: 被引用 446 件2013 年: 被引用 510 件2014 年: 被引用 436 件2015 年: 被引用 489 件2016 年: 被引用 531 件2017 年: 被引用 482 件2018 年: 被引用 483 件2019 年: 被引用 1,586 件2020 年: 被引用 1,746 件2021 年: 被引用 1,674 件2022 年: 被引用 1,278 件2023 年: 被引用 942 件2024 年: 被引用 1,461 件2025 年: 被引用 609 件2026 年: 被引用 15 件1972〜1987 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 5,118 件、この内訳の 23.9%中国: 引用元論文 3,046 件、この内訳の 14.2%イタリア: 引用元論文 1,191 件、この内訳の 5.6%イギリス: 引用元論文 1,187 件、この内訳の 5.5%日本: 引用元論文 1,100 件、この内訳の 5.1%ドイツ: 引用元論文 907 件、この内訳の 4.2%フランス: 引用元論文 815 件、この内訳の 3.8%オランダ: 引用元論文 717 件、この内訳の 3.4%スペイン: 引用元論文 693 件、この内訳の 3.2%カナダ: 引用元論文 688 件、この内訳の 3.2%韓国: 引用元論文 570 件、この内訳の 2.7%オーストラリア: 引用元論文 469 件、この内訳の 2.2%
0%23.9%その他 23%

分野

  • Medicine64%
  • Biochemistry, Genetics and Molecular Biology26.1%
  • Immunology and Microbiology4.8%
  • Engineering0.9%
  • Computer Science0.7%
  • Materials Science0.6%
  • その他2.9%

トピック

  • Lung Cancer Treatments and Mutations9.8%
  • Lung Cancer Diagnosis and Treatment5.8%
  • Lung Cancer Research Studies5.4%
  • Cancer Immunotherapy and Biomarkers4.6%
  • Cancer Genomics and Diagnostics2.4%
  • HER2/EGFR in Cancer Research2%
  • その他70%

共著者

全論文

検索で開く
  1. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laura Kingsbury, Haruhiko Kondo, Mark Krasnik, Kaoru Kubota, Antoon Lerut, Gustavo Lyons, Mirella Marino, Edith M. Marom, Jan P. van Meerbeeck, Alan Mitchell, Takashi Nakano, Andrew G. Nicholson, Anna K. Nowak, Michael Peake, Thomas W. Rice, Kenneth E. Rosenzweig, Enrico Ruffini, Valerie W. Rusch, Nagahiro Saijo, Paul Van Schil, Jean‐Paul Sculier, Lynn Shemanski, Kelly Stratton, Kenji Suzuki, Yuji Tachimori, Charles F. Thomas, William D. Travis, Ming‐Sound Tsao, Andrew T. Turrisi, Johan Vansteenkiste, Hirokazu Watanabe, Yi‐Long Wu, Paul Baas, Jeremy Erasmus, Seiki Hasegawa, Kouki Inai, Kemp H. Kernstine, Hedy L. Kindler, Lee M. Krug, Kristiaan Nackaerts, Harvey I. Pass, David C. Rice, Conrad Falkson, Pier Luigi Filosso, Giuseppe Giaccone, Kazuya Kondo, Marco Lucchi, Meinoshin Okumura, Eugene H. Blackstone, F. Abad Cavaco, Emilio Ansótegui Barrera, J. Abal Arca, Isaura Parente Lamelas, A. Arnau Obrer, R. Guijarro Jorge, David Ball, G.K. Bascom, Ana Isabel Blanco Orozco, M.A. González Castro, Matthew G. Blum, Domingo Chimondeguy, Vlado Cvijanović, Sebastián Defranchi, B. de Olaiz Navarro, I. Escobar Campuzano, I. Macía Vidueira, E. Fernández Araujo, Felipe Andreo García, Kwun M. Fong, Gloria Francisco Corral ほか 52 名 - Journal of Thoracic Oncology 2016 被引用: 4,643

  2. Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC

    著者: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2020 被引用: 1,691

  3. Targeting the dynamic HSP90 complex in cancer

    著者: , , , - Nature reviews. Cancer 2010 被引用: 1,528

  4. Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2014 被引用: 1,744

  5. The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fergus Gleeson, Patti A. Groome, James Huang, Catherine Kennedy, Jhingook Kim, Young Tae Kim, Laura Kingsbury, Haruhiko Kondo, Mark Krasnik, Kaoru Kubota, Antoon Lerut, Gustavo Lyons, Mirella Marino, Edith M. Marom, Jan P. van Meerbeeck, Alan Mitchell, Takashi Nakano, Andrew G. Nicholson, Anna K. Nowak, Michael Peake, Thomas W. Rice, Kenneth E. Rosenzweig, Enrico Ruffini, Valerie W. Rusch, Nagahiro Saijo, Paul Van Schil, Jean‐Paul Sculier, Lynn Shemanski, Kelly Stratton, Kenji Suzuki, Yuji Tachimori, Charles F. Thomas, William D. Travis, Ming‐Sound Tsao, Andrew Turrisi, Johan Vansteenkiste, Hirokazu Watanabe, Yi‐Long Wu, Paul Baas, Jeremy Erasmus, Seiki Hasegawa, Kouki Inai, Kemp H. Kernstine, Hedy L. Kindler, Lee M. Krug, Kristiaan Nackaerts, Harvey I. Pass, David C. Rice, Conrad Falkson, Pier Luigi Filosso, Giuseppe Giaccone, Kazuya Kondo, Marco Lucchi, Meinoshin Okumura, Eugene H. Blackstone - Journal of Thoracic Oncology 2016 被引用: 728

  6. Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1–Selected NSCLC

    著者: , , , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2021 被引用: 202

  7. Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2012 被引用: 551

  8. The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James Huang, Catherine J. Kennedy, Jhingook Kim, Young Tae Kim, Laura Kingsbury, Haruhiko Kondo, Mark Krasnik, Kaoru Kubota, Antoon Lerut, Gustavo Lyons, Mirella Marino, Edith M. Marom, Jan P. van Meerbeeck, Alan Mitchell, Takashi Nakano, Andrew G. Nicholson, Anna K. Nowak, Michael Peake, Thomas W. Rice, Kenneth E. Rosenzweig, Enrico Ruffini, Valerie W. Rusch, Nagahiro Saijo, Paul Van Schil, Jean‐Paul Sculier, Lynn Shemanski, Kelly Stratton, Kenji Suzuki, Yuji Tachimori, Charles F. Thomas, William D. Travis, Ming‐Sound Tsao, Andrew T. Turrisi, Johan Vansteenkiste, Hirokazu Watanabe, Yi‐Long Wu, Paul Baas, Jeremy Erasmus, Seiki Hasegawa, Kouki Inai, Kemp H. Kernstine, Hedy L. Kindler, Lee M. Krug, Kristiaan Nackaerts, Harvey I. Pass, David C. Rice, Conrad Falkson, Pier Luigi Filosso, Giuseppe Giaccone, Kazuya Kondo, Marco Lucchi, Meinoshin Okumura, Eugene H. Blackstone, F. Abad Cavaco, Emilio Ansótegui Barrera, J. Abal Arca, Isaura Parente Lamelas, A. Arnau Obrer, R. Guijarro Jorge, David Ball, G.K. Bascom, Ana Isabel Blanco Orozco, M. A. González Castro, Matthew G. Blum, Domingo Chimondeguy, Vlado Cvijanović, Sebastián Defranchi, B. de Olaiz Navarro, I. Escobar Campuzano, I. Macía Vidueira ほか 56 名 - Journal of Thoracic Oncology 2017 被引用: 507

  9. A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer

    著者: , , , , , , , , , , , , , , , , , , - European Journal of Cancer 2015 被引用: 272

  10. Targeting HER2 aberrations as actionable drivers in lung cancers: phase II trial of the pan-HER tyrosine kinase inhibitor dacomitinib in patients with HER2-mutant or amplified tumors

    著者: , , , , , , , , , , - Annals of Oncology 2015 被引用: 332

  11. Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jacques Cadranel, C. Chouaïd, Alexis B. Cortot, D. Debieuvre, B. Delclaux, Fabrice Denis, Boris Duchemann, Claude El Kouri, François‐Régis Ferrand, M. Ginoux, Werner Hilgers, Anne Madroszyk, Patrick Masson, Julien Mazières, O. Molinier, Denis Moro‐Sibilot, Éric Pichon, Céline Mascaux, G. Robinet, Benoît Roch, Gérard Zalcman, Gerlinde Schmidtke-Schrezenmeier, Wolfgang Schuette, László Urbán, Maya Gottfried, Hovav Nechushtan, Nir Peled, M. Wollner, Alona Zer, Editta Baldini, Laura Bonanno, Andrea Bonetti, Federico Cappuzzo, Angelo Delmonte, Domenico Galetta, Michele Maio, V. Minotti, Antonio Rea, Gianpiero Romano, Davide Tassinari, Giuseppe Tonini, Rafał Dziadziuszko, Bogusława Karaszewska, Aleksandra Szczęsna, Manuel Cobo, J. De Castro, Enriqueta Felip, M.R. García Campelo, Ainhoa Hernández, Teresa Morán, Mariano Provencio, Santiago Viteri, Abhijit Dasgupta, Nashat Gabrail, Giuseppe Giaccone, A. Harshad, Stephen V. Liu, D. Oubre, Rajiv Panikkar, M. Razaq, Rachel E. Sanborn - Annals of Oncology 2023 被引用: 70

  12. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Haruhiko Kondo, Mark Krasnik, Kaoru Kubota, Kaoru Kubota, Gustavo Lyons, Mirella Marino, Edith M. Marom, Jan P. van Meerbeeck, Alan Mitchell, Takashi Nakano, Andrew G. Nicholson, Anna K. Nowak, Michael Peake, Thomas W. Rice, Kenneth E. Rosenzweig, Enrico Ruffini, Valerie W. Rusch, Nagahiro Saijo, Paul Van Schil, Jean‐Paul Sculier, Lynn Shemanski, Kelly Stratton, Kenji Suzuki, Yuji Tachimori, Charles F. Thomas, William D. Travis, Ming‐Sound Tsao, Andrew T. Turrisi, Johan Vansteenkiste, Hirokazu Watanabe, Yi‐Long Wu, Hirokazu Watanabe, Jeremy Erasmus, Seiki Hasegawa, Kouki Inai, Kemp H. Kernstine, Hedy L. Kindler, Lee M. Krug, Kristiaan Nackaerts, Harvey I. Pass, David C. Rice, Conrad Falkson, Pier Luigi Filosso, Giuseppe Giaccone, Kazuya Kondo, Marco Lucchi, Meinoshin Okumura, Eugene H. Blackstone, F. Abad Cavaco, Emilio Ansótegui Barrera, J. Abal Arca, Isaura Parente Lamelas, A. Arnau Obrer, I. Parente Lamelas, David Ball, G.K. Bascom, Ana Isabel Blanco Orozco, M.A. González Castro, Matthew G. Blum, Domingo Chimondeguy, Vlado Cvijanović, Sebastián Defranchi, B. de Olaiz Navarro, I. Escobar Campuzano, B. de Olaiz Navarro, E. Fernández Araujo, F. Andreo García, Kwun M. Fong, Gloria Francisco Corral, S. Cerezo González ほか 52 名 - Journal of Thoracic Oncology 2015 被引用: 424

  13. Classification of current anticancer immunotherapies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jérôme Galon, Abhishek D. Garg, François Ghiringhelli, Giuseppe Giaccone, Eli Gilboa, Sacha Gnjatic, Axel Hoos, Anne Hosmalin, Dirk Jäger, Paweł Kaliński, Klas Kärre, Oliver Kepp, Rolf Kiessling, John M. Kirkwood, Eva Klein, Alexander Knuth, Claire E. Lewis, Roland Liblau, Michael T. Lotze, Enrico Lugli, J P Mach, Fabrizio Mattei, Domenico Mavilio, Ignacio Melero, Cornelis J.M. Melief, Elizabeth A. Mittendorf, Lorenzo Moretta, Adekunke Odunsi, Hideho Okada, A. Karolina Palucka, Marcus E. Peter, Kenneth J. Pienta, Angel Porgador, George C. Prendergast, Gabriel A. Rabinovich, Nicholas P. Restifo, Naiyer A. Rizvi, Catherine Sautès‐Fridman, Hans Schreiber, Barbara Seliger, Hiroshi Shiku, Bruno Silva‐Santos, Mark J. Smyth, Daniel E. Speiser, Radek Špíšek, Pramod K. Srivastava, James E. Talmadge, Éric Tartour, Sjoerd H. van der Burg, Benoı̂t J. Van den Eynde, Richard G. Vile, Hermann Wagner, Jeffrey S. Weber, Theresa L. Whiteside, Jedd D. Wolchok, Laurence Zitvogel, Weiping Zou, Guido Kroemer - Oncotarget 2014 被引用: 470

  14. Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2021 被引用: 103

  15. Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study

    著者: , , , , , , , , , , , , , - The Lancet Oncology 2018 被引用: 400

  16. Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH

    著者: , , , , , , , , , , , , , - Cell Death and Differentiation 2020 被引用: 133

  17. Advancements in small cell lung cancer

    著者: , , - Seminars in Cancer Biology 2023 被引用: 81

  18. The Integrated Genomic Landscape of Thymic Epithelial Tumors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Junya Fujimoto, Cristovam Scapulatempo‐Neto, André L. Moreira, David Hwang, James Huang, Mirella Marino, Robert J. Korst, Giuseppe Giaccone, Yesim Gökmen‐Polar, Sunil Badve, Arun Rajan, Philipp Ströbel, Nicolas Girard, Ming‐Sound Tsao, Alexander Marx, Anne S. Tsao, Patrick J. Loehrer, Adrian Ally, Elizabeth L. Appelbaum, J. Todd Auman, Miruna Balasundaram, Saianand Balu, Madhusmita Behera, Rameen Beroukhim, Mario Berríos, Giovanni Blandino, Tom Bodenheimer, Moiz S. Bootwalla, Jay Bowen, Denise Brooks, Flavio Mavignier Cárcano, Rebecca Carlsen, André Lopes Carvalho, Patricia Castro, Lara Chalabreysse, Lynda Chin, Juok Cho, Gina Choe, Eric Chuah, Sudha Chudamani, Carrie Cibulskis, Leslie Cope, Matthew G. Cordes, Daniel Crain, Erin Curley, Timothy Defreitas, John A. Demchok, Frank Detterbeck, Noreen Dhalla, Hendrik Dienemann, W. Jeff Edenfield, Francesco Facciolo, Martin L. Ferguson, Scott Frazer, Catrina C. Fronick, Lucinda A. Fulton, Robert S. Fulton, Stacey Gabriel, Johanna Gardner, Julie M. Gastier‐Foster, Nils Gehlenborg, Mark Gerken, Gad Getz, David I. Heiman, Shital Hobensack, Andrea Holbrook, Robert A. Holt, Alan P. Hoyle, Carolyn M. Hutter, Michael Ittmann ほか 88 名 - Cancer Cell 2018 被引用: 383

  19. Sex and cancer immunotherapy: Current understanding and challenges

    著者: , , , , , , , , - Cancer Cell 2022 被引用: 65

  20. First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors

    著者: , , , , , , , , , , , , , - Annals of Oncology 2017 被引用: 225

  21. Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

    著者: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 被引用: 650

  22. A Phase I Dose Escalation Study with Anti-CD44v6 Bivatuzumab Mertansine in Patients with Incurable Squamous Cell Carcinoma of the Head and Neck or Esophagus

    著者: , , , , , , , - Clinical Cancer Research 2006 被引用: 316

  23. Update on Hsp90 Inhibitors in Clinical Trial

    著者: , , , , , , - Current Topics in Medicinal Chemistry 2009 被引用: 307

  24. Phase I study of the 177Lu-DOTA0-Tyr3-Octreotate (lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lung

    著者: , , , , , , - Journal for ImmunoTherapy of Cancer 2020 被引用: 85